Autres langues Revolution Medicines, Inc.

Actions

RVMD

US76155X1000

Temps réel estimé Cboe BZX Autres places de cotation 16:32:20 17/05/2024			Varia. 5j.	Varia. 1 janv.
39 ^USD	+0,01 %		+4,70 %	+35,98 %

09/05	REVOLUTION MEDICINES, INC. : Wedbush réitère son opinion positive sur le titre	ZM
08/05	La perte nette de Revolution Medicines au premier trimestre se réduit	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Revolution Medicines Q1 Net Loss Narrows	08/05
Revolution Medicines : RVMD Corporate Presentation	08/05
Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress	08/05
Revolution Medicines, Inc. Reiterates Earnings Guidance for the Full Year 2024	08/05
Revolution Medicines, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Revolution Medicines to Report Financial Results for First Quarter 2024 After Market Close on May 8, 2024	01/05
North American Morning Briefing : Stock Futures -2-	11/04
Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins	09/04
Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins	08/04
Aethon Therapeutics Announces Collaboration with Revolution Medicines to Discover and Develop Novel Aethon Antibody Programs	05/04
Revolution Medicines to Participate in Upcoming Investor Conferences	04/04
Aethon Therapeutics, Inc. Announces Collaboration with Revolution Medicines, Inc. to Discover and Develop Novel Aethon Antibody Programs	04/04
Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024	28/03
Revolution Medicines Insider Sold Shares Worth $805,652, According to a Recent SEC Filing	13/03
Revolution Medicines Files Mixed-Securities Shelf	05/03
Revolution Medicines Q4 Net Loss Widens, Revenue Drops	26/02
Revolution Medicines, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/02
Earnings Flash (RVMD) REVOLUTION MEDICINES Posts Q4 Revenue $742,000, vs. Street Est of $1.2M	26/02
Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress	26/02
Revolution Medicines, Inc. Provides Earnings Guidance for Full Year 2024	26/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Revolution Medicines, Inc.

Actions

RVMD

US76155X1000

Autres langues

Filtres